Disc Medicine Inc (NASDAQ: IRON) on Friday, plunged -11.50% from the previous trading day, before settling in for the closing price of $90.44. Within the past 52 weeks, IRON’s price has moved between $30.82 and $99.50.
Annual sales at Healthcare sector company grew by 38.12% over the past five years. The company achieved an average annual earnings per share of -55.70%. With a float of $27.10 million, this company’s outstanding shares have now reached $35.01 million.
Disc Medicine Inc (IRON) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Disc Medicine Inc is 28.72%, while institutional ownership is 71.40%. The most recent insider transaction that took place on Dec 17 ’25, was worth 68,968. In this transaction Director of this company sold 754 shares at a rate of $91.47, taking the stock ownership to the 14,013 shares. Before that another transaction happened on Dec 17 ’25, when Company’s Affiliate proposed sale 50 for $87.49, making the entire transaction worth $4,374.
Disc Medicine Inc (IRON) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.98 earnings per share (EPS) for the period topping the consensus outlook (set at -1.1) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.82 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -55.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.17% during the next five years compared to 38.12% growth over the previous five years of trading.
Disc Medicine Inc (NASDAQ: IRON) Trading Performance Indicators
Disc Medicine Inc (IRON) is currently performing well based on its current performance indicators. A quick ratio of 23.45 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.36, a number that is poised to hit -1.75 in the next quarter and is forecasted to reach -6.90 in one year’s time.
Technical Analysis of Disc Medicine Inc (IRON)
Disc Medicine Inc (NASDAQ: IRON) saw its 5-day average volume 1.33 million, a positive change from its year-to-date volume of 0.44 million. As of the previous 9 days, the stock’s Stochastic %D was 24.04%.
During the past 100 days, Disc Medicine Inc’s (IRON) raw stochastic average was set at 54.81%, which indicates a significant increase from 30.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.95 in the past 14 days, which was higher than the 3.23 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $87.48, while its 200-day Moving Average is $62.35. Nevertheless, the first resistance level for the watch stands at $90.89 in the near term. At $101.74, the stock is likely to face the second major resistance level. The third major resistance level sits at $111.49. If the price goes on to break the first support level at $70.30, it is likely to go to the next support level at $60.55. Assuming the price breaks the second support level, the third support level stands at $49.70.
Disc Medicine Inc (NASDAQ: IRON) Key Stats
Market capitalization of the company is 3.02 billion based on 37,750K outstanding shares. Right now, sales total 0 K and income totals -109,360 K. The company made 0 K in profit during its latest quarter, and -62,320 K in sales during its previous quarter.
